The stock price of Petros Pharmaceuticals skyrocketed in the early hours of Wednesday’s trading, following an announcement that its STENDRA tablets have seen a 476% growth in sales year-over-year, thanks to an exclusive agreement with Hims & Hers Health Inc.
A key provider of therapeutics for Men’s health, Petros entered an exclusive, digital health marketing partnership with Hims & Hers – a telehealth platform at the forefront of innovative, modern treatments for consumers. The erectile dysfunction tablet STENDRA saw exponential success on the platform, provoking a further expansion of the partnership via further dosage availability on the His & Hers platform.
Fady Boctor, CCO and President of Petros stated:
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
“Our continued relationship with Hims supports an industry-leading telehealth platform that allows individuals to inquire about and address erectile dysfunction with discretion and by way of a convenient method of healthcare engagement,”
Adding…
“With significant growth year-over-year of STENDRA tablet sales through Hims, we are excited to expand our collaboration with Hims and enhance access to STENDRA through this critical channel.”
The data comes at a much-needed time for Petros, with the company showing a 25% loss over 2021 even with the current price spike. Consistent stock support is needed for PTPI stock to break its heavy bearish trend – PTPI is trading at $3.33, losing some momentum with a daily gain of 86%.
Should You Invest in Petros Pharmaceuticals Shares?
One of the most frequently asked questions we receive is, “what stocks are best to buy right now?” It’s a wide-ranging question, but one that we have answered… Our AskTraders stock analysts regularly review the market and compile a list of which companies you should be adding to your portfolio, including short and longer-term positions. Here are the best stocks to buy right now
[optin-monster slug=”p0ejbloqlwcce16kx3do”]
